WELLS FARGO & COMPANY/MN - PERNIX THERAPEUTICS HLDGS IN ownership

PERNIX THERAPEUTICS HLDGS IN's ticker is PTX and the CUSIP is 71426V108. A total of 47 filers reported holding PERNIX THERAPEUTICS HLDGS IN in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of PERNIX THERAPEUTICS HLDGS IN
ValueSharesWeighting
Q3 2016$3,000
+50.0%
4,7510.0%0.00%
Q2 2016$2,000
-88.9%
4,751
-72.7%
0.00%
Q1 2016$18,000
-56.1%
17,372
+25.2%
0.00%
Q4 2015$41,000
-44.6%
13,880
-40.8%
0.00%
Q3 2015$74,000
-97.8%
23,448
-95.9%
0.00%
-100.0%
Q2 2015$3,374,000
-64.6%
570,004
-36.0%
0.00%
-50.0%
Q1 2015$9,518,000
+168.9%
890,398
+136.2%
0.00%
+100.0%
Q4 2014$3,539,000
+29391.7%
376,924
+24503.4%
0.00%
Q3 2014$12,000
-69.2%
1,532
-64.9%
0.00%
Q2 2014$39,0004,368
+436700.0%
0.00%
Q1 2014$0
-100.0%
1
-99.9%
0.00%
Q3 2013$3,000
-25.0%
1,0000.0%0.00%
Q2 2013$4,0001,0000.00%
Other shareholders

There were no reported owners of PERNIX THERAPEUTICS HLDGS IN in Q3 2016.

NameSharesValueWeighting ↓
View complete list of PERNIX THERAPEUTICS HLDGS IN shareholders